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ABSTRACT 
Objective To understand the evolving market of commercial off-the-shelf Computerized Physician Order Entry 
(CPOE) and Computerized Decision Support (CDS) applications and its effects on their uptake and 
implementation in English hospitals. 
Methods Although CPOE and CDS vendors have been quick to enter the English market, uptake has been 
slow and uneven. To in- vestigate this, the authors undertook qualitative ethnography of vendors and adopters 
of hospital CPOE/CDS systems in England. The authors collected data from semi-structured interviews with 
11 individuals from 4 vendors, including the 2 most entrenched suppliers, and 6 adopter hospitals, and 21 h of 
ethnographic observation of 2 user groups, and 1 vendor event. The research and analysis was informed by 
insights from studies of the evolution of technology fields and the emergence of generic COTS enterprise 
solutions. 
Results Four key themes emerged: (1) adoption of systems that had been developed outside of England, (2) 
vendors’ configuration and customization strategies, (3) localized adopter practices vs generic systems, and 
(4) unrealistic adopter demands. Evidence for our over-arching finding concerning the current immaturity of 
the market was derived from vendors’ strategies, adopters’ reactions   to the technology, and policy makers’ 
incomplete insights. 
Conclusions The CPOE/CDS market in England is still in an emergent phase. The rapid entrance of diverse 
products, triggered by federal policy initiatives, has resulted in premature adoption of systems that do not yet 
adequately meet the needs of hospitals. Vendors and adopters lacked understanding of how to design and 
implement generic solutions to meet diverse user needs. 
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Computerized Physician Order Entry (CPOE) and Computerized Decision Support (CDS) systems have the 
potential to deliver many benefits.1 Stakeholders managing health systems in many countries have invested 
substantial efforts to implement and deploy such systems.2 The United States has been among the leading 
countries in deploying these systems in hospitals.2 England has similarly invested considerable resources in 
commercial off-the-shelf (COTS) CPOE and CDS systems. Calls by the National Health Service (NHS) in 
England to improve the quality, safety, and efficiency of healthcare, have promoted considerable interest in 
the timely implementation of these systems, which in the United Kingdom are more commonly referred to as 
“ePrescribing.”3,4 
These systems are well established in England’s primary care,5,6 and several attempts have been made 
to further implement them in hospitals. A key national initiative was the National Programme for Information 
Technology (NPfIT), in which selected software applications were to be centrally procured and 
implemented.7,8 However, NPfIT encountered numerous problems and the Department of Health instituted a 
change of direction toward local selection of systems by individual hospitals.8 This move has stimulated 
competition and resulted in hospitals being confronted by a range of vendor options, none of which are 
currently perceived as fully meeting the needs of the English market.3 Similar problems were initially 
encountered in the US market.9 
The CPOE/CDS market in England is faced with substantial uncertainty and is currently undergoing rapid 
change and evolution.2,3 Our earlier work has highlighted the move away from “home-grown” to COTS 
systems, prompted by the very substantial costs  associated with developing and maintaining bespoke 
applications, and problems with limited interoperability between different hospital systems.10,11 Standardized 
COTS systems, built around generic models of the user organization, may however be far removed from 
local workflows, necessitating considerable efforts to adjust local working practices and/ or to reconfigure and 
customize software.12,13 The lack of maturity of systems, their limited tailoring to the English context, diversity 
and ambiguity of options, and difficulties achieving change in long-established organizational practices all 
contribute to the challenges that hospitals face in realizing benefits.3,4,14,15,16 
This paper aims to improve understanding of the state of development of the CPOE/CDS market, 
encompassing both vendor and adopter perspectives in relation to the evolution and maturity of the market, 
and its consequences for the pace and success of implementation of COTS systems in NHS hospitals. This 
work is timely, as it has the potential to inform policy and practice in relation to the growing in- vestments 
being made in procuring and implementing systems not only in England, but also in many other high- and 
middle-income countries. 
 
DESIGN AND METHODS 
We utilized a qualitative research design, building on earlier studies of the current status of the English 
hospital CPOE/CDS market,3,4 collecting data from both vendors and adopters. 
 
Theoretical Framework: Understanding the Evolution of Technology Markets/Fields 
In order to understand the evolution of the CPOE/CDS market in England, examination of its current stage 
in the technology development cycle is helpful. Scholars from various disciplines have advanced staged 
models of the evolution of industrial sectors and products, which characterize progression of the markets 
with respect to various factors such as the number of vendors, the range of design models, and innovation 
patterns over time.17 Agarwal and Tripsas18 offer a three-stage model of product and market evolution: 
emergence/ growth, shakeout, and maturity. In the emergence/growth stage, there is a high uncertainty on 
both the technology supply and demand sides. Many firms may enter the market. Products are adopted 
unevenly, and as products become established, dominant models start to emerge. Customers’ expectations 
become clearer and their preferences become stabilized, leading to a shakeout in the range of firms and 
products. Finally, in the mature phase, the technological and competitive environment stabilizes. Product 
innovation is overtaken by the rationalization of supply of standardized solutions.18 
Studies of the provision of application software as “packaged” COTS solutions have highlighted difficulties 
faced by adopters in assessing the fit to their needs of these complex nonmaterial products—particularly in 
the early, emergent stage of the product lifecycle when there is limited understanding of the overall utility of 
the application class and the strengths of particular products. Vendors conversely need to understand the 






for this range.13 The emergence of dominant designs and consensus about the characteristics of a technology 
help to ameliorate these uncertainties in design and procurement faced by vendors and adopters.12,19,20 
However, commodification pressures toward standardization may be reversed by further— particularly 
discontinuous—innovation. Thus changes in technological solutions and organizational goals and shifts to 
new market segments may reverse maturation and take the product back to the emergence stage.21 
 
Institutional Review Board Approval and Ethical Considerations 
This study is a part of a national research program investigating the implementation and adoption of 
ePrescribing (CPOE/CDS) systems in English hospitals, which received ethical approval from The University 
of Edinburgh’s Research Ethics Committee. We also received guidance from the NHS Health Research 
Authority National Research Ethics Service (NRES) Committee London City and East that the study did not 
require review from an NHS ethics committee. 
 
Sampling and Recruitment 
The data obtained for this work is composed of publicly available documents and semi-structured interviews 
with participants from vendor and users who had given their written informed consent to participate. We also 
collected data from observation of user groups (periodic meetings organized by vendors which brought 
together users from across the country and other third-party organizations interested in their products) and a 
meeting organized by our project which brought together six vendors of CPOE/CDS systems in England. 
Participants in the user groups and this vendor event gave verbal/signed consent to be observed for this 
study. Interview and observation data were anonymized for analysis. Building on our recent survey of the 
current status of the English CPOE/CDS market, we developed a purposive sampling framework of current 
vendors and adopters of various CPOE/CDS systems in English hospitals to provide a multi-perspective 
view.3,22,23 
In order to develop a comprehensive picture, our purposive sample included at least one vendor or adopter 
from each system type within our typology that distinguished: standalone systems, modules within an 
integrated system, and distributed functionality among several modules.3 This included both established and 
more recently emerging products. Apart from one widely adopted UK system and an Italian system, the 
majority of systems examined come from the United States. 
Potential respondents were approached in person or by e-mail. In total, we contacted 8 vendors, and 8 
hospitals that had implemented or were in the process of implementing CPOE/CDS. Of these, 4 vendors and 
6 hospitals agreed to participate. These 10 organizations fulfilled our requirement of having at least 1 vendor 
or 1 adopter from each of the CPOE/CDS types. In each case, we used purposive sampling to identify at 
least 1 person who had been involved in implementation of the system in English hospitals (a member of the 
project management team which ranged from doctors and pharmacists in adopter sites to project managers 
in vendor sites). This allowed us to investigate both vendor and adopter perspectives on the possible influence 
of the type of systems and the stages of their lifespan in England. 
 
Data Collection 
Our data collection methods consisted of semi-structured interviews and ethnographic observation. The 
study team  benefits  from  over  40 years of cumulative experience in conducting and analyzing qualitative 
research in health and other sectors. The use of qualitative and ethnographic methods in the study of 
technology in health contexts is potentially very valuable in addressing emerging developments which are 
subject to uncertainty and divergent perspectives which can other- wise be hard to understand.24 This 
combination of methods enabled  us to investigate the reported experience of different entities as well  as 
the nature of the interactions involved in adoption and implementation of systems in England. It also allowed 
us to triangulate results to facilitate credibility of our findings.25 
The interviews were semi-structured, with the interview guide focusing on 4 main areas: (a) the current 
status and development trajectory of CPOE/CDS systems in England; (b) strategies in design, development, 
and adaptation; (c) problems faced during implementation and their possible causes; and (d) the vendor-
user relationship throughout the project lifecycle. The interview guides were tailored to the roles of individuals 
and further refined throughout the research based on the findings of prior interviews. The interviews ranged 








Three of our 4 selected vendors held English user group meetings. To provide wider context and aid the 
interpretation of our data, we requested to attend and observe those meetings, which offered particular 
opportunities to observe directly how user requirements and concerns were articulated through the user 
group and vendor responses to these. Two vendors agreed to allow access. Data from user group meetings 
consisted of researcher field notes around three main areas: (a) the technological contents of the discussion; 
(b) supplier-user relationships; and (c) decisions being taken. 
 
We also observed a vendor event. This event gathered vendors to discuss their experience of 
implementation of CPOE/CDS system in English hospitals and discuss their concern and challenges in this 
process. Researcher field notes were recorded around 3 main themes: (a) challenges and opportunities for 
vendors from the early stages of project initiation to implementation, (b) vendors’ experiences of go-live and 
system stabilization, and (c) vendors’ views on system optimization and enhancements. 
Data were collected over the period from October 2012 to October 2014. The interviews were audio-
recorded and transcribed verbatim. One interviewee from the vendor group preferred not to be directly 
quoted, but nevertheless agreed for their views to be accounted for in the analysis. We continued data 
collection until we judged that no new themes were identified and saturation was reached.26 
 
Data Analysis 
Data collection and analysis took place simultaneously to allow emerging themes to be fed back into future 
data collection. The analysis was performed using a thematic approach. We began with an inductive analysis 
of the data collected from different sources to identify pat- terns of emerging issues. This involved reading 
each interview, comparing transcripts and “searching across data sets” to find “patterns of meanings.”27 The 
codes were then grouped into themes. In forming each theme we cross analyzed vendor and adopter quotes 
to incorporate both viewpoints. 
 
RESULTS 
We interviewed 11 individuals  from 10 organizations (4 vendors and  6 adopter hospitals) and performed 
21 h of observation of user group and vendor events. We identified 4 key tensions in the design and 
implementation of CPOE/CDS systems concerning the more or less diverging perspectives of vendors and 
adopters, highlighting tensions and the strategies being pursued to ameliorate these. 
 
Adoption of systems that had been developed overseas 
We have previously highlighted that most systems available in England originated in other countries.3 
Several adopters stated that implementing such systems in English hospitals could be problematic “as their 
[US] way of working is very different to the UK based working.” (Adopter Interview, P2). The lack of alignment 
between system functionalities and internal hospital processes such as workflows and medicines practices 
was seen as a major barrier to implementation by adopters. 
 
.. . [Product Name] is a U.S. system and it works very well for a 
U.S. hospital, but some things in the U.K. are quite different, specially around medicines practices and we 
are still working with [Supplier Name] to see if we can get some of their products changed to better reflect 
our workflow (Adopter Interview, P4) 
 
Similar problems have been observed in the adoption in Dutch hospitals of US solutions due to differences 
in workflow and practices as well as language.28 
Vendors were aware of these national differences and highlighted their efforts to tailor their product to the 
English context. 
 
An interface to a formulary vendor for medications is standard in the US but we obviously had to go above 
and beyond, knowing that there are different requirements, there’s different information on drugs in the 
U.K (Vendor Interview, P6) 
 
While some overseas vendors (particularly those with limited presence in the English market) appeared 
reluctant to invest the significant resources needed to implement these changes, others (and particularly 





their products. In localizing the systems, they were undergoing multiple cycles of modification. However, with 
only a handful of implementations in English hospitals, most systems were seen as still in the early stages of 
being “Anglicized.” This is a concept that was coined by UK health professionals to highlight difficulties in 
adopting organizational concepts29 and more recently information systems30,31 arising from the United States 
with its different institutions and practices. Here we use the term more generically to refer to the customization 
of international systems for the UK market. 
 
One example, which highlights differences in secondary care between the UK and United States in the 
processes by which medications are given to patients to take home as they are discharged is “to take out” 
(TTO) medication. While in the United States discharged patients receive a print out of their medication which 
they can fulfil at any pharmacy, in the UK, before the patient is fully discharged, doctors prescribe “take out” 
medications and patients need to go to the hospital pharmacy to pick up the orders. 
 
. . .  we have our own like UK ring, like the ability to place a TTO [To Take Out] medication order. That 
requirement does not exist in America, you cannot place a TTO order in the system in the States but in 
our [UK] ring you can so that’s like one kind of big custom that we’ve done for our UK sites here ..  . 
 
There was thus a national requirement to modify the US package to transfer such prescriptions electronically 
to the pharmacy and distinguish them from inpatient medications. The vendor achieved this by adding 
customized “flags” onto the package’s existing process for an “ambulatory medication order.” 
 
[We] still utilise the system kind of how it’s intended to be used but deliver what our customers [in the 
UK] need and it was to create an additional flag on that ambulatory medication order that if this flag exists 
the order gets sent electronically. So in the US system there is physically no way to send an ambulatory 
medication order to the pharmacy system, we created a customised, you know, method of delivering that 
order so that pharmacists see a TTO order on their list and they know oh  that was a TTO that was 
ordered not an inpatient medication.” (Vendor Interview, P7) 
 
In the above example, “UK ring” refers to the Anglicized version of a US developed product. A new business 
process has been added to meet the English market requirement. However, our work suggests that efforts 
to develop generic Anglicized versions of products are still in their infancy. 
 
. . .  after several hospitals [in U.S.] were up running live and stable with the software that’s pretty  much 
the version  that  we  took  as  our  initial  like  U.K.   kind   of   starting   point And basically, where we 
started there were certain items that we knew were going to be different in the U.K. (Vendor Interview, 
P7) 
 
This resulted in system architectures that were inadequate and/or sub-optimal for the English market. Users 
who were implementing international systems in the hope of achieving benefits of their advanced 
functionalities found themselves caught in an unanticipated and slow process of joint system (re)development 
with the vendor.  Vendors were under pressure to tailor systems to reflect the national and local particularities 
of the English context. They were therefore confronted with the need to identify both: 1) the generic English 
hospitals’ needs and 2) the specific needs of diverse adopting hospitals. 
 
Vendor configuration and customization strategies 
Vendors of packaged solutions need to develop effective “generification” strategies for addressing 
demands from their diverse user-base for modifications and new functionality.12 Rather than respond 
reactively to a flood of disparate modification requests, they need to develop and retain a vision for the 
software, and maintain control over the overall architecture of their product as it moves forward. This allows 
them to priorities change requests, identify those they are unable or unwilling to support, and those to be 
undertaken  by  adopters  themselves.  To achieve this, established software packages are designed 
around a basic set of functionalities: the “generic kernel.”13 The adopter organization can then configure 
systems by selecting from a library of “templates” encompassing typical work processes in the sector, 
constructed around these core functions, and configure them to meet their local needs. Such software 






predefined configurations are limited and do not meet users’ needs, adopters may ask for soft- ware 
program changes. However, such local customization can adversely affect system upgrades and 
maintenance.21 
We found that CPOE/CDS vendors had made uneven progress in developing generification strategies for the 
English market. While some responded to user demands reactively (and often reluctantly), others were more 
pro-active in seeking user input into system design. As a result, some adopters observed that vendors “very 
rarely offer specific solutions” to their particular needs. On the other hand vendors explained that such needs 
might be “too specific” to be incorporated into the generic system. Moreover, feedback from user groups 
indicated that most solutions were viewed by adopters as “too limited” in terms of configurability (user allowed 
customizations) and customization. Hence there was an ongoing dispute between what users demanded as 
configurability and what vendors referred to as specific customization needs. 
 
Localized adopter practices versus generic systems 
Implementation of generic systems further foregrounded variations in local hospital practices. Operational 
differences between hospitals, which had not previously been evident, became visible. Participants, 
particularly from the vendor side, therefore highlighted the need to introduce best practice standards to the 
sector in order to be able to develop more generic systems. 
 
.. . every NHS trust in the country considers themselves to be different . . .  if you give them a standard 
OBS [output based specification] . . .  they make it unique to them . . .  every ques- tion [on the OBS]  has  a  
nuanced,  has  a  little  twist  in there . . .  (Comment by vendor in vendor event) 
 
The lack of standard practices became even more apparent with systems with higher levels of integration. 
 
Unrealistic adopter demands 
A potential underlying reason for many of the challenges identified may be the lack of user awareness 
surrounding the characteristics of packaged applications, resulting in unrealistic expectations. For example, 
the majority of users interviewed expressed a desire for local practices to be directly incorporated into the 
system. 
 
... we are all doing the same job but we are managing the processes differently, so when we implement 
technologies we all want to implement it in our own way (Adopter Interview, P1) 
. . .  some of the changes we are asking [Product_Name] for are things that individual Trusts [hospitals] 
do .. . (Adopter Interview, P4) 
 
Vendors referred to these expectations as “over-aspirational functional specifications” (vendor comment at 
vendor event). For instance  in user group meetings we observed cases where some users asked for a 
change of color for particular types of text on the screen, or a reduction in the number of clicks needed to 
perform certain tasks. The former might be simple to implement (though arguably users would quickly get 
used to this) while the latter might require more complex and potentially costly changes in source code. 
 
. . .  if I want the colour of the medication name to turn  blue.  OK well why  do you want it to turn blue, do 
you really want   that or do you just want something about it to be noticeable? Does it have to be blue; 
it’s really just about opening that line   of communication and figuring out well what’s the need behind 
what you’re saying. (Vendor Interview, P7) 
 
Some adopters held (unrealistic) expectations that interfaces would be designed around specific methods 
of working in their hospital. The key challenge stemmed from the diversity of modification requests arising in 
an ad hoc manner from various groups of users. This posed multiple conflicting demands on developers. 
To avoid such “untamed” unrealistic adopter demands, vendors identified the need to build alignment from 
the earliest opportunity between user expectations and actual system purposes and functions. There were 
also difficulties within hospitals in fully specifying system requirements for procurement. This led some 
adopters to propose direct links between the vendor and the hospital to help elicit their specific requirements 






So companies I’ve worked for before have always had [ .. . ] a user that partly worked in the Trust 




We identified several tensions in the design and implementation of CPOE/CDS systems in England: 
 
1. the ad hoc management of user modification requests has proved problematic, 
 
2. many products are limited in configurability and need to be customized to suit the needs of adopters and 
Anglicized versions of foreign developed packages have not yet been stabilized, 
3. adopters contrasted the specificity of their work practices to generic vendor offerings, and  
4. adopters often had unrealistic demands—for example, in terms of the level of specificity of local practice 
that packaged applications would catering for. 
 
Progress with procuring and implementing CPOE/CDS applications in England is proceeding slowly. This 
may be due to the fact that the market is still in an early stage of emergence/growth.18 Despite the presence 
of various vendors, each has a relatively small number of implementations in progress and there is high 
technical variety  in terms of system architectures and features.3 Products vary significantly in function and 
there is, to date, little evidence of the emergence of de facto standards or “dominant designs” in the English 
market,18,32 although existing international research has repeatedly highlighted desirable features of 
systems.33–39 Our previous work has shown that the absence of agreed national guidelines has resulted in 
diverse adopter procurement strategies and largely ad hoc vendor responses to end-user requests.40 
The limited adopter understanding of available options and the heterogeneity of user demands to modify 
vendors’ products could lead to ambiguity in characterizing the target product or rejection of systems with 
standardized modules or interfaces.18,41–43 A lack of clear user prefer- ences,44 the existence of varied 
workflows,15,34 and the diversity of offerings from vendors exemplifies a market that is still in the emergence/ 
growth stage. This is particularly noteworthy given that effective CPOE/ CDS requires fit between user workflows 
and vendors’ products.15,28 
 
Implications for Policy and Practice 
Another way in which the field appears immature is that it has not yet developed structures and actors to 
mobilize consensus and set the boundaries of technology—a role carried out in other sectors by industry 
analysts like Gartner12 and by entities such as the Health Information Technology Standards Committee, 
certification criteria and certifying organizations in the United States. Guidelines based on successful 
implementation experience may help reduce procurement uncertainties—for example, by enabling 
development of generic cases for innovations, creating a space for comparison of different artefacts and 
vendors, and helping users come to more realistic and realizable expectations about CPOE/CDS 
functionalities and their effective deployment. 
We observed a misalignment between the functionality offered by generic packages and the requirements 
of adopting organizations.34,45 Sustained adopter pressures for customization left little space for vendors to 
achieve effective generification strategies. To overcome this, adopters need to better understand vendors’ 
packages and associated opportunities and challenges. 
There is a need for more effective accommodation between the vendors’ generification strategies and 
diverse localized hospital practices. This can be achieved by adhering to configurability principles by 
developing systems in a way that caters for diversities in workflows and operations.46,47 
Finally, there is a need to clarify the technological field around CPOE/CDS systems. This calls for 
engagement and consensus not only between adopters and vendors, but also larger communities including 
policymakers, field experts, and intermediaries such as industry analysts and implementation consultants. 
A more specific implication for policy and practice concerns the need for more gradual development of 
this immature technology market. Thus, rather than seeking rapid large-scale implementation  of their 








markets to accommodate for differentials in processes and practices. For CPOE/CDS systems this might 
include a two stage implementation plan: basic (comprising drug-allergy checking, basic dosing, formulary 
decision support, and checks on duplicate prescribing, and drug–drug interaction) and advanced 
(comprising variable range dosing, interactions with laboratory testing, and drug–disease contraindication 
checking).33 
 
Strengths, limitations, and future research 
Our work provides significant insights into why the rapid entrance of commercial CPOE/CDS systems into 
the secondary care market in England was followed by a slow and often difficult adoption experience. 
Conducting a study that involved both vendors and adopters of the technology helped us gain an 
understanding of demand and supply issues. Involving several organizations in the investigation allowed us 
to gather perspectives from adopters and vendors of different types of systems originating from a variety 
of countries. 
There are a number of limitations to our study, including our theoretical framework. While there is research 
into how vendors develop packaged solutions products for diverse users through (generification) strategies 
and linkages with adopters, we do not yet have systematic understanding of how these operate at the level 
of technology fields/ markets. The maturity of a technology field seems to be an important factor 
underpinning the rate and success of implementation. And the procurement of integrated information 
systems seems to display continued challenges. Further work is needed addressing organizational and 
sectoral characteristics in tandem. 
Our work has highlighted particular issues arising when systems that originated in one national context 
are applied elsewhere.13 This issue besets attempts to implement, in the UK, hospital CPOE/CDS systems 
arising within differently organized health services. Globalization of supply, driven in part by the scale of 
investment required, gives added importance to this topic – with many applications being offered more 
widely across the English speaking world. Translation is not just a linguistic matter,28 but depends also upon 
detailed differences in work practices, information processes, national and organizational cultures, and 
contextual factors that may not be readily appreciated in advance. More systematic cross-national research 
is needed into increasingly globalized system development and implementation to give insight into market 
adaptation and systems adoption. 
As we have highlighted, the CPOE/CDS market in England is still in its emergence phase, with many new 
vendors and hospitals in the early stages of adoption. Hence, our sample consisted mainly of early adopters. 
Although these user organizations were not necessarily representative of all hospitals in England, they 
provided useful insights into some of the most important issues arising when a new technology enters the 
health sector. Furthermore, as the technological field around CPOE/CDS is not yet well established, other 
currently unknown actors may emerge to influence the growth of these systems. We note the continued 
dynamism of electronic health applications that may further shape the field, including extension in technical  
functionalities and increasing integration between applications. This highlights the need to continue to 
independently evaluate this rapidly evolving landscape. We have provided a starting point for this work. 
 
CONCLUSIONS 
This paper explored the state of development of the CPOE/CDS market and its the consequences for the 
implementation of COTS systems in NHS hospitals in England. Though system procurement in NHS England 
became decentralized again, following the demise of NPfIT, it continues to be shaped by strong national 
incentives, particularly for CPOE/CDS. Diverse products have entered the market. However neither 
developers nor adopting organizations seem adequately prepared for the complexities of transformations 
required. Although policy incentives can be effective in promoting adoption,2 they may also have accelerated 
premature procurement of immature solutions. Vendors may need to adopt more strategic long-term (e.g., 
generification) approaches to the development of their offerings in catering for di- verse needs. Adopting 
hospitals need to have more realistic expectations in relation to packaged applications with limited 
configurability. Mechanisms to bridge the gap between generic, standardized technological solutions and 









It is further important to remember that CPOE/CDS is not a final stage, but serves as an important stepping-
stone in the integration of healthcare systems and services, wherein such software functionality will become 
a fundamental part of health information infrastructures.34 In order to achieve this, there is an urgent need to 
appreciate existing complexities and heterogeneities outlined in this work. These issues have international 
applicability as an increasing number of countries strive to stimulate CPOE/CDS adoption.2,48–50 
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